[1] Zhang Lusi,Hill Scot Kristian,Guo Bin,et al.Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders.[J]. Progress in neuro-psychopharmacology & biological psychiatry, 2021, 113(8): 110464-110464. [2] 何伟. 为精神病合并高血压患者使用不同方法进行治疗的效果评价[J].当代医药论丛,2019,17(4):14-15. [3] 王一浩. 非勺型高血压患者在夜间睡前服用苯磺酸氨氯地平进行治疗的效果观察[J].当代医药论丛,2021,19(9):103-104. [4] 赵馨,郭小兵,王贵山,等.住院精神病患者并发躯体疾病的临床特点分析[J].神经损伤与功能重建,2020,15(6):366-367. [5] Zhang Fuquan,Baranova Ancha,Zhou Chao, et al.Causal influences of neuroticism on mental health and cardiovascular disease.[J]. Human genetics, 2021, 140(9) : 1-15. [6] 陈静静,职彦敏,郭宁宁,等.住院精神病病人2250例肝炎病毒感染及其影响因素的logistic回归分析[J].安徽医药,2022,26(6):1137-1141. [7] Berry Alexandra, Yung Alison R, Carr Matthew J, et al.Prevalence of Major Cardiovascular Disease Events Among People Diagnosed With Schizophrenia Who Have Sleep Disturbance, Sedentary Behavior, or Muscular Weakness.[J]. Schizophrenia bulletin open, 2021, 2(1) : 69. [8] 余学,肖雪,马良.社区重症精神疾病患者共病心血管疾病的现状及危险因素[J].临床精神医学杂志,2021,31(4):309-312. [9] Doreen Mucheru, Mary-Claire Hanlon, Linda E.Campbell, et al. Cardiovascular disease lifestyle risk factors in people with psychosis: a cross-sectional study[J]. BMC Public Health, 2018, 18(1) : 1-14. [10] 何小琴. 苯磺酸氨氯地平片在社区高血压病治疗中的有效性及安全性评价[J].中国保健营养,2019,29(29):283-284. [11] 孙秀杰,董彦文,牧骑,等.苯磺酸左旋氨氯地平用于继发性高血压治疗中的安全性与有效性分析[J].中外医疗,2021,40(1):91-93 [12] 陈益,王亮,魏咏兰,等.邛崃市免费体检老年人群心血管病危险因素流行与聚集情况分析[J].实用预防医学,2022,29(3):327-331. |